Protective efficacy induced by Mycobacterium bovis bacille Calmette-Guèrin can be augmented in an antigen independent manner by use of non-coding plasmid DNA

Vaccine

Volumn 24, Issue 1, 2006, Pages 95-101

  Hogarth, Philip J ^a   Logan, Karen E ^a   Ferraz, Jose Candido ^b   Hewinson, R Glyn ^a   Chambers, Mark A ^a  

^a VETERINARY LABORATORIES AGENCY   (United Kingdom)

^b NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

Author keywords

BCG; Prime boost; Tuberculosis; Vaccine

Indexed keywords

BCG VACCINE; CYTOKINE; DNA VACCINE; GAMMA INTERFERON; HEAT SHOCK PROTEIN 65; HEAT SHOCK PROTEIN 70; INTERLEUKIN 12; PLASMID DNA; PRIMER DNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL COUNT; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFICACY; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; GENETIC CODE; IMMUNE RESPONSE; IMMUNITY; IMMUNIZATION; INOCULATION; MOUSE; MYCOBACTERIUM BOVIS; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL;

ANIMALS; BCG VACCINE; FEMALE; IMMUNIZATION; INTERFERON TYPE II; INTERLEUKIN-12; MICE; MICE, INBRED BALB C; PLASMIDS; VACCINES, DNA;

EID: 28344442864     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2005.07.115     Document Type: Article

References (39)

1. J.R. Krebs Bovine Tuberculosis in Cattle and Badgers 1997 Ministry of Agriculture, Fisheries and Food London
2. A. Kochi The global tuberculosis situation and the new control strategy of the World Health Organization Tubercle 72 1 1991 1 6
3. O. Cosivi, F.X. Meslin, C.J. Daborn, and J.M. Grange Epidemiology of Mycobacterium bovis infection in animals and humans, with particular reference to Africa Rev Sci Tech 14 3 1995 733 746
4. B.R. Bloom, and P.E. Fine The BCG experience: implications for future vaccines against tuberculosis B.R. Bloom Tuberculosis: Pathogenesis, Protection and Control 1994 ASM Press Washington, DC 531 557
5. R.G. Hewinson, H.M. Vordermeier, and B.M. Buddle Use of the bovine model of tuberculosis for the development of improved vaccines and diagnostics Tuberculosis (Edinb) 83 1-3 2003 119 130
6. I.M. Orme, D.N. McMurray, and J.T. Belisle Tuberculosis vaccine development: recent progress Trends Microbiol 9 3 2001 115 118
7. A.M. Cooper, D.K. Dalton, T.A. Stewart, J.P. Griffin, D.G. Russell, and I.M. Orme Disseminated tuberculosis in interferon gamma gene-disrupted mice J Exp Med 178 6 1993 2243 2247
8. J.L. Flynn, J. Chan, K.J. Triebold, D.K. Dalton, T.A. Stewart, and B.R. Bloom An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection J Exp Med 178 6 1993 2249 2254
9. T.H. Ottenhoff, D. Kumararatne, and J.L. Casanova Novel human immunodeficiencies reveal the essential role of type-I cytokines in immunity to intracellular bacteria Immunol Today 19 11 1998 491 494
10. R.A. Taha, T.C. Kotsimbos, Y.L. Song, D. Menzies, and Q. Hamid IFN-gamma and IL-12 are increased in active compared with inactive tuberculosis Am J Respir Crit Care Med 155 3 1997 1135 1139
11. S.G. Rhodes, N. Palmer, S.P. Graham, A.E. Bianco, R.G. Hewinson, and H.M. Vordermeier Distinct response kinetics of gamma interferon and interleukin-4 in bovine tuberculosis Infect Immun 68 9 2000 5393 5400
12. M.A. Skinner, A.J. Ramsay, G.S. Buchan, D.L. Keen, C. Ranasinghe, and L. Slobbe A DNA prime-live vaccine boost strategy in mice can augment IFN-gamma responses to mycobacterial antigens but does not increase the protective efficacy of two attenuated strains of Mycobacterium bovis against bovine tuberculosis Immunology 108 4 2003 548 555
13. I.S. Leal, B. Smedegard, P. Andersen, and R. Appelberg Failure to induce enhanced protection against tuberculosis by increasing T-cell-dependent interferon-gamma generation Immunology 104 2 2001 157 161
14. H.M. Vordermeier, M.A. Chambers, P.J. Cockle, A.O. Whelan, J. Simmons, and R.G. Hewinson Correlation of ESAT-6-specific gamma interferon production with pathology in cattle following Mycobacterium bovis BCG vaccination against experimental bovine tuberculosis Infect Immun 70 6 2002 3026 3032
15. J.L. Flynn, and J. Chan Immunology of tuberculosis Annu Rev Immunol 19 2001 93 129
16. D.L. Woodland Jump-starting the immune system: prime-boosting comes of age Trends Immunol 25 2 2004 98 104
17. C.G. Feng, U. Palendira, C. Demangel, J.M. Spratt, A.S. Malin, and W.J. Britton Priming by DNA immunization augments protective efficacy of Mycobacterium bovis Bacille Calmette-Guerin against tuberculosis Infect Immun 69 6 2001 4174 4176
18. H. McShane, R. Brookes, S.C. Gilbert, and A.V. Hill Enhanced immunogenicity of CD4(+) t-cell responses and protective efficacy of a DNA-modified vaccinia virus Ankara prime-boost vaccination regimen for murine tuberculosis Infect Immun 69 2 2001 681 686
19. A. Tanghe, S. D'Souza, V. Rosseels, O. Denis, T.H. Ottenhoff, and W. Dalemans Improved immunogenicity and protective efficacy of a tuberculosis DNA vaccine encoding Ag85 by protein boosting Infect Immun 69 5 2001 3041 3047
20. M.A. Skinner, B.M. Buddle, D.N. Wedlock, D. Keen, G.W. de Lisle, and R.E. Tascon A DNA prime-Mycobacterium bovis BCG boost vaccination strategy for cattle induces protection against bovine tuberculosis Infect Immun 71 9 2003 4901 4907
21. H.M. Vordermeier, S.G. Rhodes, G. Dean, N. Goonetilleke, K. Huygen, and A.V. Hill Cellular immune responses induced in cattle by heterologous prime-boost vaccination using recombinant viruses and bacille Calmette-Guerin Immunology 112 3 2004 461 470
22. M.A. Chambers, H.M. Vordermeier, R.G. Hewinson, and D.B. Lowrie DNA vaccines against bacterial pathogens H.J.C. Hildegund DNA Vaccines 2003 Eurekah Bioscience Georgetown 161 194
23. M.J. McCluskie, R.D. Weeratna, and H.L. Davis The role of CpG in DNA vaccines Springer Semin Immunopathol 22 1-2 2000 125 132
24. R.E. Tascon, M.J. Colston, S. Ragno, E. Stavropoulos, D. Gregory, and D.B. Lowrie Vaccination against tuberculosis by DNA injection Nat Med 2 8 1996 888 892
25. D.B. Lowrie, C.L. Silva, M.J. Colston, S. Ragno, and R.E. Tascon Protection against tuberculosis by a plasmid DNA vaccine Vaccine 15 8 1997 834 838
26. A. Garapin, L. Ma, P. Pescher, M. Lagranderie, and G. Marchal Mixed immune response induced in rodents by two naked DNA genes coding for mycobacterial glycosylated proteins Vaccine 19 20-22 2001 2830 2841
27. D.B. Lowrie, R.E. Tascon, V.L. Bonato, V.M. Lima, L.H. Faccioli, and E. Stavropoulos Therapy of tuberculosis in mice by DNA vaccination Nature 400 6741 1999 269 271
28. T. Garnier, K. Eiglmeier, J.C. Camus, N. Medina, H. Mansoor, and M. Pryor The complete genome sequence of Mycobacterium bovis Proc Natl Acad Sci USA 100 13 2003 7877 7882
29. J. Gallagher, and D.M. Horwill A selective oleic acid albumin agar medium for the cultivation of Mycobacterium bovis J Hyg (Lond) 79 1 1977 155 160
30. http://www.sanger.ac.uk/Projects/M_bovis/
31. S.J. McConkey, W.H. Reece, V.S. Moorthy, D. Webster, S. Dunachie, and G. Butcher Enhanced T-cell immunogenicity of plasmid DNA vaccines boosted by recombinant modified vaccinia virus Ankara in humans Nat Med 9 6 2003 729 735
32. A.M. Cooper, A.D. Roberts, E.R. Rhoades, J.E. Callahan, D.M. Getzy, and I.M. Orme The role of interleukin-12 in acquired immunity to Mycobacterium tuberculosis infection Immunology 84 3 1995 423 432
33. A.M. Cooper, J. Magram, J. Ferrante, and I.M. Orme Interleukin 12 (IL-12) is crucial to the development of protective immunity in mice intravenously infected with Mycobacterium tuberculosis J Exp Med 186 1 1997 39 45
34. B.L. Freidag, G.B. Melton, F. Collins, D.M. Klinman, A. Cheever, and L. Stobie CpG oligodeoxynucleotides and interleukin-12 improve the efficacy of Mycobacterium bovis BCG vaccination in mice challenged with M. tuberculosis. Infect Immun 68 5 2000 2948 2953
35. D.M. Klinman, G. Yamshchikov, and Y. Ishigatsubo Contribution of CpG motifs to the immunogenicity of DNA vaccines J Immunol 158 8 1997 3635 3639
36. Y. Sato, M. Roman, H. Tighe, D. Lee, M. Corr, and M.D. Nguyen Immunostimulatory DNA sequences necessary for effective intradermal gene immunization Science 273 5273 1996 352 354
37. J.C. Ferraz, E. Stavropoulos, M. Yang, S. Coade, C. Espitia, and D.B. Lowrie A heterologous DNA priming-Mycobacterium bovis BCG boosting immunization strategy using mycobacterial Hsp70, Hsp65, and Apa antigens improves protection against tuberculosis in mice Infect Immun 72 12 2004 6945 6950
38. R.L. Skjot, I. Brock, S.M. Arend, M.E. Munk, M. Theisen, and T.H. Ottenhoff Epitope mapping of the immunodominant antigen TB10.4 and the two homologous proteins TB10.3 and TB12.9, which constitute a subfamily of the esat-6 gene family Infect Immun 70 10 2002 5446 5453
39. P.J. Hogarth, K.E. Logan, H.M. Vordermeier, M. Singh, R.G. Hewinson, and M.A. Chambers Protective immunity against Mycobacterium bovis induced by vaccination with Rv3109c - a member of the esat-6 gene family Vaccine 23 2005 2557 25564